The human HepG2/erythrocyte glucose-transporter gene, including the promoter region, has been isolated and characterized. The gene, which is -35,000 base pairs, is interrupted by nine intervening sequences or introns. The sequence of the HepG2 glucosetransporter protein predicted from the gene sequence differs from that determined from the published cDNA sequence in having Leu rather than Phe at position 152. In addition, there are several other nucleotide differences between the gene and cDNA sequences in both the coding region and 3-untranslated region that do not alter the amino acid sequence of the protein. The sequence of the promoter and the site of transcription initiation have also been determined. The promoter region includes a TATA motif and two binding sites for the transcription factor Spl as well as a sequence that is found in the promoter region of several phorbol ester-inducible genes. Diabetes 37:657-61, 1988 G lucose enters most mammalian cells by a carriermediated facilitated diffusion mechanism (1). This uptake has no energy or counterion requirements and depends only on the glucose concentration gradient. cDNA clones encoding the facilitative glucose transporter expressed in a human hepatoma cell line (HepG2; 2) and rat brain (3) have been isolated from cDNA-expression libraries with polyclonal antibodies to purified human erythrocyte glucose transporter.
G lucose enters most mammalian cells by a carriermediated facilitated diffusion mechanism (1) . This uptake has no energy or counterion requirements and depends only on the glucose concentration gradient. cDNA clones encoding the facilitative glucose transporter expressed in a human hepatoma cell line (HepG2; 2) and rat brain (3) have been isolated from cDNA-expression libraries with polyclonal antibodies to purified human erythrocyte glucose transporter.
The HepG2 and rat brain cDNA clones both encode a 492-amino acid protein whose sequence is remarkably well conserved; there is 98% identity between the human and rat proteins. Analysis of the primary structure suggests that this protein has 12 membrane-spanning domains and that the NH 2 -and COOH-termini as well as a highly charged and hydrophilic region in the center of the protein are probably located within the cell. The regions of the protein that comprise the channel through which glucose moves are unknown.
Studies of genes encoding other membrane proteins suggest that the exon/intron organization of the gene can be a useful guide for predicting regions with different functions, because in many instances exons encode protein segments with differing functional capabilities (4) . The gene structure also provides a basis for comparison with other related genes and for studies of potentially abnormal genes. We describe the organization of the human gene encoding the HepG2/erythrocyte facilitative glucose transporter and the sequence of its promoter region. The abundance of HepG2 glucose-transporter mRNA in different human tissues and solid tumors was also determined.
MATERIALS AND METHODS
General methods. Standard procedures were carried out as described by Maniatis et al. (5) . Human tissues were obtained with institutional approval and informed consent. For Northern blots, 20 fig of total RNA was denatured with glyoxal and, after electrophoresis through a 1 %-agarose gel, transferred to a nitrocellulose filter. Probes were labeled by nick translation. The hybridization conditions have been described previously (6) . DNA sequencing was done by the dideoxy-chain-termination procedure (7) after subcloning appropriate DNA fragments into M13mp18 or 19. Both the universal primers and sequence-specific oligonucleotides were used as primers. Isolation of human glucose-transporter gene. Segments of the human gene were isolated from the partial Hae\\\/Alu\ fetal human liver library in \Ch4A of Lawn et al. (8) by hybridization with the human HepG2 glucose-transporter cDNA (9) . The sequences of the exons and adjacent introns were determined. The positions of the exon-intron junctions were assigned via the "GT-AG rule" (10) . Primer extension. The start of transcription was determined by primer extension with a modification of the procedure described by Gil et al. (11) . Fifty micrograms of total placenta RNA and 75 fmol of the oligonucleotide 3'-CCCTCGTCCTCTGGTTTGCT-5' (complementary to nucleotides 68-87 of the gene sequence), which were 5'-end labeled with [7 32 P]ATP and polynucleotide kinase, were dissolved in 24 (xl of a solution containing 50 mM Tris-HCI (pH 8.3), 50 mM KCI, 8 mM MgCI 2 , and 20 mM dithiothreitol. After denaturation at 95°C for 4 min, the mixture was annealed at 56°C for 45 min. To initiate primer extension, 1.5 (JLI of a 10-mM solution of each dNTP (dATP, dGTP, dCTP, and dTTP), 1.5 |xl of 1 mg/ml actinomycin D, and 3 |xl (75 U) of reverse transcriptase were added, and the reaction was incubated at 45°C for 15 min. The reaction mixture was extracted with an equal volume of phenol and CHCI 3 -isoamyl alcohol (1:1). The primer-extended products were precipitated with ethanol, resuspended in formamide, heated at 95°C, and separated on a 5% polyacrylamide, 8-M urea gel. A sequencing ladder obtained with this primer on the appropriate template was run in adjacent lanes to deduce the size of the extended product and the sequence at which the primer extension terminated.
RESULTS
The human HepG2/erythrocyte glucose-transporter gene was isolated as a series of overlapping DNA fragments that span ~55 kiiobase pairs (kbp; (Table 1 ). The overall distribution of the exons is rather striking with exons 3-10 grouped together in a region of ~7 kbp and separated from exons 1 and 2 by -2 8 and 12 kbp, respectively. All the introns interrupt the protein sequence in regions predicted to be in surface loops or very close to the inner or outer surface of the plasma membrane (2) .
The sequence of the mRNA predicted from that of the gene differed from the published cDNA sequence (2) in several instances: the codon for Ala-15 was GCC rather than GCU (GCC was also present at this position in independently isolated cDNA clone \hGT2; 9), amino acid 152 was Leu (CUU) in both the gene and \hGT2 rather than Phe (UUU), and the codon for Asp-476 was GAC rather than GAU. The gene sequence encoding the 3'-end of the cDNA contained one substitution and lacked two nucleotides present in the cDNA sequence (cf. Fig. 4 The sequence of the 5'-flanking region and the transcription-initiation site were also determined. The site of transcription initiation (Fig. 2) , deduced by primer extension (Fig.  3) , was located 16 bases upstream of the 5'-end of the cDNA clone \hGT2. Thus, the 5'-untranslated region of this mRNA is 217 bases. The promoter region contained several different types of transcriptional control elements (Fig. 2) , including a TATA box, two binding sites for the transcription factor Spl (12) , and a sequence that is found in the promoter region of several phorbol ester [tetradecanoylphorbol acetate (TPA)]-inducible genes, and functions as a TPA-inducible enhancer/TPA-responsive element (TRE; 13).
The sequence of the 3'-end of the mRNA has not been determined. Moreover, the sequence of the region immediately downstream of the published cDNA sequence (2) does not contain a canonical polyadenylation signal, AA-TAAA, and therefore it is not possible to predict the position of the 3'-end of the mRNA (Fig. 4) .
The abundance of HepG2/erythrocyte glucose-transporter mRNA in different tissues and solid tumors varies widely (2,3,14; Fig. 5 ). The highest levels are found in RNA isolated from term placenta. Lower levels (~ 10-25% of the amount presented in term placenta) are present in adult colon, kidney, and cerebrum, and much lower levels (^5% of the amount in placenta) are found in adult stomach, jejunum, gallbladder, and adipose tissue (subcutaneous fat from the region of the thigh). The HepG2 glucose-transporter mRNA levels in RNA prepared from adult liver and skeletal muscle (semitendinous) were below the sensitivity of our assay; however, other investigators have reported the presence of low levels of HepG2 glucose-transporter mRNA in RNA prepared from adult rat liver (3, 14) and human skeletal muscle from the leg of a diabetic subject (14) . HepG2 glucose-transporter mRNA was also observed in one of three hepatomas and in a colon carcinoma specimen. The probe hybridized to a single transcript of ~3.0 kb in all tissues.
DISCUSSION
The HepG2/erythrocyte glucose-transporter gene is a single-copy gene and has been mapped to the p35->p31.3 region of the short arm of human chromosome 1 (9) . Several restriction-fragment-length polymorphisms (RFLPs) associated with this gene have also been identified by use of cDNA probes (9, 15) . Examination of the isolated gene indicates that the BglW RFLP is located in the 5'-flanking region -4.5 kbp upstream of exon 1, and the Xba\ RFLP is located in the second intron -4.5 kbp upstream of exon 3.
From their analysis of the amino acid sequence of the HepG2 glucose transporter, Mueckler et al. (2) predicted that the protein spans the plasma membrane 12 times and has a large extracellular loop between the first and second membrane-spanning segments as well as a large and highly charged intracellular loop between membrane-spanning segments 6 and 7. The COOH-terminal 42 residues are predicted to be located on the cytoplasmic side of the membrane. Their model suggests that the protein is composed of -15 domains. The exon/intron organization of the glucose-transporter gene indicates that each exon encodes 1-3 of the predicted protein domains (Fig. 6) . A similar correspondence of exons and protein domains has been reported for several other membrane proteins including the low-density lipoprotein receptor (16) and human myelin proteolipid protein (17) . However, there are also exam- The sites at which introns interrupt the mRNA and protein sequences are indicated. Exon sequences are in capital letters, and intron sequences are in lowercase letters. The sizes of the introns were estimated by restriction mapping or DNA sequencing.
pies of membrane proteins in which exons do not encode domains, e.g., the p-adrenergic receptor (18) .
In most mammalian cells, glucose enters by facilitated diffusion (1) . However, in the kidney and intestinal epithelia, glucose uptake also occurs by active transport via a Na + -glucose cotransporter. The presence of mRNA encoding the HepG2/erythrocyte glucose transporter in many different human and rat tissues ( Fig. 5; refs. 2,3,14) , including placenta, kidney, brain, small and large intestine, stomach, and adipose tissue, suggests that this transporter is at least partly responsible for the glucose uptake by these tissues. However, the very low levels of this mRNA in adult liver and skeletal muscle are rather surprising, because these tissues together with brain represent the major sites of glucose disposal. It seems likely that another protein is responsible for facilitative glucose uptake in liver and muscle.
Glucose uptake is regulated by at least three independent mechanisms, including activation of a pool of existing glucose transporters, alteration of protein turnover, and induction of glucose-transporter biosynthesis (reviewed in ref. 1). Flier et al. (19) have demonstrated that treatment of fibroblasts with phorbol esters (TPA) results in increased glucose uptake and elevation of HepG2 glucose-transporter mRNA levels. The sequence of the HepG2 glucose-transporter gene promoter revealed the presence of a conserved sequence that is present in other genes whose expression is induced by TPA (13) , and it is likely that the increased mRNA levels after TPA treatment result at least partly from increased transcription. The isolation and characterization of the HepG2 glucose-transporter gene promoter presented herein will facilitate a direct test of the role of various sequence elements in the regulation of its expression.
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